Abstract
Gene therapy has emerged as a promising approach for various clinical conditions, yet the efficient and controlled delivery of viral vectors remains a challenge. The Sendai virus (SeV) stands out as an innovative alternative to traditional vectors, offering high transduction efficiency, exclusively cytoplasmic replication, and reduced mutagenic risk. To enhance its therapeutic potential, …